IndraLab
Statements
sparser
"Collectively, these findings position DUBs as master regulators of neuroinflammatory and neuroprotective responses in CIRI, operating through: (i) direct ubiquitin code editing of inflammasome components (BRCC3-NLRP6, CYLD-NLRP3), (ii) multi-layered control of NF-κB signaling (A20/TRAF6, CYLD-TRAF2/6, OTUD1/RIP2, USP25/TAB2), (iii) dynamic modulation of microglial polarization states (USP8-TLR4, USP14-REST), and critically, (iv) axonal integrity preservation via UCHL1-mediated stabilization of synaptic scaffolds (PSD-95/neurofilaments), offering a compelling therapeutic paradigm for targeted immunomodulation in IS."